Related references
Note: Only part of the references are listed.A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (ChronocortTM) vs. conventional hydrocortisone (CortefTM) in the treatment of congenital adrenal hyperplasia
Somya Verma et al.
CLINICAL ENDOCRINOLOGY (2010)
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline
Phyllis W. Speiser et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Extraadrenal 21-Hydroxylation by CYP2C19 and CYP3A4: Effect on 21-Hydroxylase Deficiency
Larissa G. Gomes et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Neonatal screening for congenital adrenal hyperplasia
Perrin C. White
NATURE REVIEWS ENDOCRINOLOGY (2009)
Fast and direct quantification of adrenal steroids by tandem mass spectrometry in serum and dried blood spots
Nils Janzen et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2008)
Evaluation and treatment of hirsutism in premenopausal women: An endocrine society clinical practice guideline
Kathryn A. Martin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: The Mayo Clinic experience (2004-2007)
D. Matern et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
Neonatal screening in Europe; the situation in 2004
J. Gerard Loeber
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
Newborn screening for congenital adrenal hyperplasia: Additional steroid profile using liquid chromatography-tandem mass spectrometry
N. Janzen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: Deceleration of growth velocity during puberty
Walter Bonfig et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Congenital adrenal hyperplasia and P450 oxidoreductase deficiency
Nils Krone et al.
CLINICAL ENDOCRINOLOGY (2007)
Expanded newborn screening for biochemical disorders: The effect of a false-positive result
Elizabeth A. Gurian et al.
PEDIATRICS (2006)
Automated, fast and sensitive quantification of 17 alpha-hydroxy-progesterone, androstenedione and testosterone by tandem mass spectrometry with on-line extraction
Manfred Rauh et al.
STEROIDS (2006)
Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls
TS Varness et al.
JOURNAL OF PEDIATRICS (2005)
Cutoff levels of 17-α-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight
HJ van der Kamp et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia
F Votava et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Rapid second-tier molecular genetic analysis for congenital adrenal hyperplasia attributable to steroid 21-hydroxylase deficiency
S Kösel et al.
CLINICAL CHEMISTRY (2005)
Female preponderance in congenital adrenal hyperplasia due to CYP21 deficiency in England: Implications for neonatal screening
A Nordenstrom et al.
HORMONE RESEARCH (2005)
Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry
JM Lacey et al.
CLINICAL CHEMISTRY (2004)
Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
CE Flück et al.
NATURE GENETICS (2004)
Neonatal screening for congenital adrenal hyperplasia
HJ van der Kamp et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: Implication for neonatal screening of congenital adrenal hyperplasia
F Gatelais et al.
PEDIATRIC RESEARCH (2004)
Screening for congenital adrenal hyperplasia: Adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value
B Olgemoller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Newborn screening for congenital adrenal hyperplasia in the Netherlands
HJ Van der Kamp et al.
PEDIATRICS (2001)
Reverse dot-blot hybridization as an improved tool for the molecular diagnosis of point mutations in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency
YP Yang et al.
MOLECULAR DIAGNOSIS (2001)
Antenatal corticosteroids and newborn screening for congenital adrenal hyperplasia
JL King et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2001)
Newborn screening for congenital adrenal hyperplasia
BL Therrell
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2001)
Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasia
DP Merke et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
PC White et al.
ENDOCRINE REVIEWS (2000)
Share Paper
